The TriLink SpotLight Workshops are designed to be focused and impactful sessions with topic experts that allow you to learn and interact with Q&A. As new technologies are developed around the use of mRNA, exciting applications emerge. TriLink is a proven leader in supporting cutting-edge mRNA research, from unique raw materials to custom synthesis. Join TriLink technical expert Taylor McReynolds, MS, for this workshop on several noteworthy applications supported by TriLink mRNA services, including base editing, riboswitches, pandemic response and more.
The International mRNA Health Conference is the premier meeting destination for industry and academic professionals to explore the rapidly advancing science and business of mRNA medicines, providing participants a platform to network with colleagues, secure updates on advances in mRNA technology, and to attend scientific presentations given by the most esteemed experts in the field. This 2-day event brings together more than 450 attendees from leading pharma & biotech companies, as well as world-class academic institutions.
Conference Presentation
Dr. Anton McCaffrey, Senior Director of Emerging Science & Innovation
Strategic CDMO partnering for accelerated mRNA vaccine development: A COVID-19 case study
In celebration of mRNA Day 2020, TriLink is proud to present back-to-back webinars by two pioneers of the mRNA therapeutic platform: Dr. Katalin Kariko and Dr. Drew Weissman. Dr. Kariko will provide an overview of the history of mRNA therapeutics, while Dr. Weissman will provide his perspective on the future of mRNA medicines.
In a series of seminal manuscripts, Drs. Kariko and Weissman showed that incorporation of modified nucleotides, such as pseudouridine, in mRNAs during in vitro transcription reduces innate immune responses that block mRNA expression. Another critical discovery was that High Performance Liquid Chromatography (HPLC) purification could remove contaminating double stranded RNA from mRNA preparations, further reducing innate immune stimulation. Dr. Kariko is now Senior Vice President at BioNTech RNA Pharmaceuticals, where she works on protein replacement therapies, while Dr. Weissman’s research at the University of Pennsylvania focuses on the development of mRNA-based vaccines.
Join TriLink in celebrating mRNA Day 2020 with two pioneers of mRNA research. A live Q&A session will follow the webinar
United States 
